The Pharmaceutical Development of Inhalation Medicines and the Value of Outsourcing

Cummings,R. Harris;

The Pharmaceutical Development of Inhalation Medicines and the Value of Outsourcing

May 1, 2002

By R. Harris Cummings, PhD

Publication

Article

Pharmaceutical TechnologyPharmaceutical Technology-05-02-2002

Volume 26

Issue 5

A knowledgeable and experienced contract service provider can help in the development and success of an inhalation drug product.

External Link - article-18603.pdf

Articles in this issue

Direct Compression: Microcrystalline Cellulose Grade 12 versus Classic Grade 102

Harmonizing Standards and Specifications

Polymers in Transdermal Drug Delivery Systems

The Pharmaceutical Development of Inhalation Medicines and the Value of Outsourcing

Expanding the Use of Child-Resistant Packaging

Forced Degradation of Ibuprofen in Bulk Drug and Tablets and Determination of Specificity, Selectivity, and the Stability-Indicating Nature of the USP Ibuprofen Assay Method

Outsourcing Outlook

Analytical Data Management and Archiving: 21 CFR Part 11 Compliance and Beyond

E-Procurement  Reverse Auctions and the Supplier's Perspective

Related Content

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Circio and Certest to Collaborate on LNP Formulations

Feliza Mirasol

November 21st 2024

Article

The companies will collaborate to create and test circVec DNA–LNP formulations for use in potential therapeutic applications.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas

June 25th 2024

Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

CDMO SEKISUI Expands its CGMP Biopharma Manufacturing Capacity

Feliza Mirasol

November 20th 2024

Article

SEKISUI has used a £15.7 million (US$20.7 million) investment to expand its clinical-grade drug substance manufacturing at its UK site.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol

April 30th 2024

Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Frontier Scientific Solutions Plans a Global Free Trade Zone Gateway to Supply Life Sciences Industry on Back of $1.5 Billion Investment

Feliza Mirasol

November 16th 2024

Article

Frontier Scientific Solutions has unveiled plans to use a $1.5 billion commitment from a major investor to create a global free trade zone gateway to facilitate the life sciences supply chain using Wilmington International Airport in North Carolina.